Exscientia Analyst Ratings
BenzingaApr 22 13:20 ET
Analysts' Top Healthcare Picks: Healthequity (HQY), Exscientia Plc (EXAI)
TipRanksMar 22 03:40 ET
B of A Securities Downgrades Exscientia to Neutral, Lowers Price Target to $9
BenzingaJan 5 09:15 ET
Exscientia Analyst Ratings
BenzingaJan 5 09:14 ET
Berenberg Bank Keeps Their Buy Rating on Exscientia Plc (EXAI)
TipRanksOct 25, 2023 21:55 ET
Barclays Maintains Overweight on Exscientia, Lowers Price Target to $10
BenzingaOct 17, 2023 08:17 ET
Exscientia Analyst Ratings
BenzingaOct 17, 2023 08:16 ET
Morgan Stanley Maintains Equal-Weight on Exscientia, Lowers Price Target to $7
BenzingaOct 11, 2023 10:01 ET
Exscientia Analyst Ratings
BenzingaOct 11, 2023 10:00 ET
Morgan Stanley Cuts Exscientia Price Target to $7 From $14, Maintains Equal Weight Rating
MT NewswiresOct 10, 2023 12:13 ET
Analysts Conflicted on These Technology Names: Intel (INTC), Meta Platforms (META) and Exscientia Plc (EXAI)
TipRanksOct 4, 2023 05:31 ET
Exscientia Plc (EXAI) Receives a Buy From Barclays
TipRanksAug 11, 2023 04:35 ET
Morgan Stanley Reiterates Equal-Weight on Exscientia, Maintains $14 Price Target
BenzingaAug 1, 2023 11:12 ET
Exscientia Analyst Ratings
BenzingaAug 1, 2023 11:11 ET
Exscientia Analyst Ratings
BenzingaJul 31, 2023 09:23 ET
Morgan Stanley Reiterates Equal-Weight on Exscientia, Maintains $14 Price Target
BenzingaJul 24, 2023 09:15 ET
Exscientia Analyst Ratings
BenzingaJul 24, 2023 09:15 ET
Berenberg Initiates Coverage On Exscientia With Buy Rating, Announces Price Target of $13
BenzingaJul 21, 2023 05:15 ET
Exscientia Analyst Ratings
BenzingaJul 21, 2023 05:14 ET
The Latest Analyst Ratings for Exscientia
BenzingaJul 20, 2023 14:00 ET
No Data
No Data